These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 17511970

  • 1. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.
    Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    Biol Psychiatry; 2007 Nov 15; 62(10):1103-10. PubMed ID: 17511970
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activation of endocannabinoid transmission induces antidepressant-like effects in rats.
    Adamczyk P, Gołda A, McCreary AC, Filip M, Przegaliński E.
    J Physiol Pharmacol; 2008 Jun 15; 59(2):217-28. PubMed ID: 18622041
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.
    Jhaveri MD, Richardson D, Robinson I, Garle MJ, Patel A, Sun Y, Sagar DR, Bennett AJ, Alexander SP, Kendall DA, Barrett DA, Chapman V.
    Neuropharmacology; 2008 Jul 15; 55(1):85-93. PubMed ID: 18534634
    [Abstract] [Full Text] [Related]

  • 6. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov 15; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 7. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
    Hasanein P, Shahidi S, Komaki A, Mirazi N.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):132-5. PubMed ID: 18593578
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats.
    Lee J, Di Marzo V, Brotchie JM.
    Neuropharmacology; 2006 Sep 04; 51(3):557-65. PubMed ID: 16806299
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).
    Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D.
    CNS Drug Rev; 2006 Sep 04; 12(1):21-38. PubMed ID: 16834756
    [Abstract] [Full Text] [Related]

  • 12. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains.
    Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z.
    Behav Brain Res; 2005 Jun 03; 161(1):45-59. PubMed ID: 15904709
    [Abstract] [Full Text] [Related]

  • 13. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.
    Clapper JR, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    Pharmacol Res; 2006 Nov 03; 54(5):341-4. PubMed ID: 16935521
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan 03; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 16. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
    Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW.
    Br J Pharmacol; 2006 Feb 03; 147(3):281-8. PubMed ID: 16331291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms.
    Shahidi S, Hasanein P.
    Brain Res Bull; 2011 Aug 10; 86(1-2):118-22. PubMed ID: 21763761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.